The effect of C1-inhibitor in a murine model of transfusion-related acute lung injury

Vox Sanguinis

Volumn 107, Issue 1, 2014, Pages 71-75

  Muller M C A ^a   Stroo, I ^b   Wouters, D ^b   Zeerleder, S S ^a,b   Roelofs, J J T H ^a   Boon, L ^c   Vroom, M B ^a   Juffermans, N P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c BIOCEROS   (Netherlands)

Author keywords

C1 inhibitor; Complement; MHC I antibody; Transfusion; Transfusion related acute lung injury

Indexed keywords

CETOR; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; HLA ANTIBODY; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIBODY CLASS I; UNCLASSIFIED DRUG; ANTIBODY; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD TRANSFUSION; DISEASE MODEL; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; TRANSFUSION REACTION;

ACUTE LUNG INJURY; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES; BLOOD TRANSFUSION; BRONCHOALVEOLAR LAVAGE FLUID; COMPLEMENT ACTIVATION; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C3A; COMPLEMENT C5A; CYTOKINES; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; TRANSFUSION REACTION;

EID: 84902313569     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12128     Document Type: Article

References (13)

1. Goldman M, Webert KE, Arnold DM, et al.: Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19:2-31
2. Vlaar AP, Binnekade JM, Prins D, et al.: Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010; 38:771-778
3. Seeger W, Schneider U, Kreusler B, et al.: Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990; 76:1438-1444
4. Strait RT, Hicks W, Barasa N, et al.: MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med 2011; 208:2525-2544
5. Ambruso DR, Giclas P, Silliman CC, et al.: Complement Activation Associated with Transfusion Related Acute Lung Injury (TRALI). Hum Immunol 2005; 66:S21
6. Lucas G, Rogers S, Evans R, et al.: Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sang 2000; 79:112-115
7. Wouters D, Wagenaar-Bos I, van HM, et al.: C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin Biol Ther 2008; 8:1225-1240
8. Vlaar AP, Wolthuis EK, Hofstra JJ, et al.: Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies. Intensive Care Med 2010; 36:879-887
9. Looney MR, Su X, Van Ziffle JA, et al.: Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006; 116:1615-1623
10. Palfi M, Berg S, Ernerudh J, et al.: A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001; 41:317-322
11. Huber-Lang M, Sarma JV, Zetoune FS, et al.: Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12:682-687
12. Vlaar AP, Hofstra JJ, Determann RM, et al.: Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control study. Crit Care Med 2012; 40:2813-2820
13. Horstick G, Berg O, Heimann A, et al.: Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation 2001; 104:3125-3131